Analysis of multiple endpoints in clinical trials: it's time for the designations of primary, secondary and tertiary to go

Pharm Stat. 2011 Jan-Feb;10(1):1-2. doi: 10.1002/pst.402.
No abstract available

MeSH terms

  • Clinical Trials as Topic / statistics & numerical data*
  • Humans
  • Research Design
  • Statistics as Topic / methods*